These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 19141386

  • 1. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Ruano Y, Ribalta T, de Lope AR, Campos-Martín Y, Fiaño C, Pérez-Magán E, Hernández-Moneo JL, Mollejo M, Meléndez B.
    Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
    Jesionek-Kupnicka D, Kulczycka D, Rieske P, Szybka M, Jabłońska J, Potemski P, Kolasa P, Liberski PP, Kordek R.
    Pol J Pathol; 2007 Feb; 58(2):79-85. PubMed ID: 17715673
    [Abstract] [Full Text] [Related]

  • 4. Age-dependent prognostic effects of EGFR/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients.
    Srividya MR, Thota B, Arivazhagan A, Thennarasu K, Balasubramaniam A, Chandramouli BA, Hegde AS, Santosh V.
    J Clin Pathol; 2010 Aug; 63(8):687-91. PubMed ID: 20702468
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.
    Quan AL, Barnett GH, Lee SY, Vogelbaum MA, Toms SA, Staugaitis SM, Prayson RA, Peereboom DM, Stevens GH, Cohen BH, Suh JH.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):695-703. PubMed ID: 15936158
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y, Ushio Y.
    Cancer Res; 2003 Oct 15; 63(20):6962-70. PubMed ID: 14583498
    [Abstract] [Full Text] [Related]

  • 7. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
    Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, Benito R, Roldan P, Piquer J, Llacer J, Barbera J.
    Clin Neuropathol; 2005 Oct 15; 24(5):209-18. PubMed ID: 16167544
    [Abstract] [Full Text] [Related]

  • 8. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
    Ganigi PM, Santosh V, Anandh B, Chandramouli BA, Sastry Kolluri VR.
    Pediatr Neurosurg; 2005 Oct 15; 41(6):292-9. PubMed ID: 16293948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R, Gil-Benso R, Quilis V, Perez M, Gregori-Romero M, Roldan P, Gonzalez-Darder J, Cerdá-Nicolas M, Lopez-Gines C.
    Neuropathology; 2010 Aug 15; 30(4):392-400. PubMed ID: 20051017
    [Abstract] [Full Text] [Related]

  • 12. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):126-34. PubMed ID: 20362227
    [Abstract] [Full Text] [Related]

  • 13. Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases.
    Kim JH, Bae Kim Y, Han JH, Cho KG, Kim SH, Sheen SS, Lee HW, Jeong SY, Kim BY, Lee KB.
    Am J Surg Pathol; 2012 Apr 15; 36(4):620-8. PubMed ID: 22441548
    [Abstract] [Full Text] [Related]

  • 14. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.
    Cancer; 2006 Oct 15; 107(8):1891-7. PubMed ID: 16986124
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of p53 and p21 in primary glioblastomas.
    Gross MW, Kraus A, Nashwan K, Mennel HD, Engenhart-Cabillic R, Schlegel J.
    Strahlenther Onkol; 2005 Mar 15; 181(3):164-71. PubMed ID: 15756520
    [Abstract] [Full Text] [Related]

  • 17. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP.
    Mol Cancer Res; 2009 May 15; 7(5):665-77. PubMed ID: 19435819
    [Abstract] [Full Text] [Related]

  • 18. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1455-61. PubMed ID: 17445998
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC.
    Clin Cancer Res; 2009 Nov 01; 15(21):6683-93. PubMed ID: 19861461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.